1. Home
  2. ILMN vs FCNCA Comparison

ILMN vs FCNCA Comparison

Compare ILMN & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • FCNCA
  • Stock Information
  • Founded
  • ILMN 1998
  • FCNCA 1898
  • Country
  • ILMN United States
  • FCNCA United States
  • Employees
  • ILMN N/A
  • FCNCA N/A
  • Industry
  • ILMN Medical Specialities
  • FCNCA Major Banks
  • Sector
  • ILMN Health Care
  • FCNCA Finance
  • Exchange
  • ILMN Nasdaq
  • FCNCA Nasdaq
  • Market Cap
  • ILMN 13.1B
  • FCNCA 25.4B
  • IPO Year
  • ILMN 2000
  • FCNCA N/A
  • Fundamental
  • Price
  • ILMN $99.25
  • FCNCA $2,117.62
  • Analyst Decision
  • ILMN Buy
  • FCNCA Buy
  • Analyst Count
  • ILMN 17
  • FCNCA 10
  • Target Price
  • ILMN $124.35
  • FCNCA $2,348.40
  • AVG Volume (30 Days)
  • ILMN 2.4M
  • FCNCA 83.5K
  • Earning Date
  • ILMN 07-31-2025
  • FCNCA 07-25-2025
  • Dividend Yield
  • ILMN N/A
  • FCNCA 0.37%
  • EPS Growth
  • ILMN N/A
  • FCNCA N/A
  • EPS
  • ILMN N/A
  • FCNCA 175.01
  • Revenue
  • ILMN $4,337,000,000.00
  • FCNCA $9,091,000,000.00
  • Revenue This Year
  • ILMN N/A
  • FCNCA N/A
  • Revenue Next Year
  • ILMN $3.15
  • FCNCA $2.54
  • P/E Ratio
  • ILMN N/A
  • FCNCA $12.15
  • Revenue Growth
  • ILMN N/A
  • FCNCA N/A
  • 52 Week Low
  • ILMN $68.70
  • FCNCA $1,473.62
  • 52 Week High
  • ILMN $156.66
  • FCNCA $2,412.93
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 65.51
  • FCNCA 73.66
  • Support Level
  • ILMN $95.09
  • FCNCA $2,059.92
  • Resistance Level
  • ILMN $101.28
  • FCNCA $2,158.22
  • Average True Range (ATR)
  • ILMN 3.28
  • FCNCA 46.30
  • MACD
  • ILMN 0.10
  • FCNCA 16.43
  • Stochastic Oscillator
  • ILMN 78.82
  • FCNCA 87.46

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: